Efficient scavenger receptor-mediated uptake and cross-presentation of negatively charged soluble antigens by dendritic cells

被引:35
作者
Shakushiro, K [1 ]
Yamasaki, Y [1 ]
Nishikawa, M [1 ]
Takakura, Y [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut & Drug Metab, Sakyo Ku, Kyoto 6068501, Japan
关键词
dendritic cells : cross-presentation; MHC class I presentation; scavenger receptors; soluble antigens : negatively charged; ovalbumin;
D O I
10.1111/j.1365-2567.2004.01871.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Exogenous antigens endocytosed in large amounts by antigen-presenting cells (APC) are presented on major histocompatibility complex (MHC) class I molecules as well as on class II molecules, a process called cross-presentation. Among APC, dendritic cells (DC) play a key role in cross-presentation by transporting internalized antigen to the cytosol. The present study shows that ovalbumin (OVA) introduced with negative charges by succinylation (Suc-OVA), maleylation (Mal-OVA) or cis-aconitylation (Aco-OVA) was efficiently taken up by DC via scavenger receptors (SR). Mal-OVA and Aco-OVA were efficiently cross-presented by DC, while cross-presentation of Suc-OVA was hardly observed. MHC class I presentation of acylated OVA introduced directly into the cytosol was inefficient and presentation of exogenous native OVA but not of Aco-OVA was markedly augmented by chloroquine, an inhibitor of endosomal acidification, suggesting that deacylation in endosomes or lysosomes is necessary for cross-presentation of acylated OVA. MHC class I presentation of exogenous native OVA and Aco-OVA by DC was blocked by lactacystin and brefeldin A, demonstrating that exogenous antigens taken up by DC are cross-presented through the conventional cytosolic pathway. Therefore, SR-mediated delivery of antigen to DC leads to efficient cross-presentation, although the pathway of chemical modification should be considered.
引用
收藏
页码:211 / 218
页数:8
相关论文
共 39 条
[1]   Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes [J].
Albert, ML ;
Pearce, SFA ;
Francisco, LM ;
Sauter, B ;
Roy, P ;
Silverstein, RL ;
Bhardwaj, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (07) :1359-1368
[2]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[3]  
Bansal P, 1999, J IMMUNOL, V162, P4430
[4]   Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance [J].
Bonifaz, L ;
Bonnyay, D ;
Mahnke, K ;
Rivera, M ;
Nussenzweig, MC ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (12) :1627-1638
[5]  
Butler P J, 1972, Methods Enzymol, V25, P191, DOI 10.1016/S0076-6879(72)25016-9
[6]   Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation [J].
Delneste, Y ;
Magistrelli, G ;
Gauchat, JF ;
Haeuw, JF ;
Aubry, JP ;
Nakamura, K ;
Kawakami-Honda, N ;
Goetsch, L ;
Sawamura, T ;
Bonnefoy, JY ;
Jeannin, P .
IMMUNITY, 2002, 17 (03) :353-362
[7]  
DUNCAN JR, 1993, J NUCL MED, V34, P1728
[8]  
Fanger NA, 1996, J IMMUNOL, V157, P541
[9]   THE BIOCHEMISTRY AND CELL BIOLOGY OF ANTIGEN PROCESSING AND PRESENTATION [J].
GERMAIN, RN ;
MARGULIES, DH .
ANNUAL REVIEW OF IMMUNOLOGY, 1993, 11 :403-450
[10]  
GRANT EP, 1995, J IMMUNOL, V155, P3750